Brandon BioCatalyst (formerly Medical Research Commercialisation Fund / MRCF)

Investment thesis

Australasia's largest life science commercialisation collaboration (established 2007 as the MRCF, renamed Brandon BioCatalyst in 2022). Brings together 50+ medical research institutes and hospitals, super funds and federal/state governments to invest in early-stage medical discoveries. Managed by Brandon Capital, with >A$800m under management.

Sector focus